Insight to Combat Post COVID-19 Mortality: Complications and their Biomarkers

被引:0
|
作者
Srivastava, Rajnish [1 ]
Patel, Pankaj Singh [2 ]
Dev, Suresh Kumar [3 ]
Pradhan, Joohee [2 ]
Panchawat, Sunita [2 ]
机构
[1] Moradabad Educ Trust Grp Inst, Fac Pharm, Moradabad, Uttar Pradesh, India
[2] Mohanlal Sukhadia Univ, Dept Pharmaceut Sci, Udaipur, Rajasthan, India
[3] Pacific Acad Higher Educ & Res Univ, Pacific Coll Pharm, Udaipur, Rajasthan, India
关键词
COVID-19; molecular pathogenesis; biomarker; pulmonary mucormycosis; pulmonary fibrosis; pulmonary aspergillosis; INVASIVE PULMONARY ASPERGILLOSIS; PATHOLOGICAL FINDINGS; CYTOKINE STORM;
D O I
10.2174/1566524022666220812111830
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background COVID-19 is a severe acute respiratory syndrome that has become a prominent source of morbidity and mortality around the world. With millions infected globally by the COVID-19 epidemic, long-term care for COVID-19 survivors has become a global concern. As a result, research into the long-term pulmonary and extrapulmonary consequences and complications of COVID is absolutely necessary. Objectives In an attempt to better understand and mitigate post recovery mortality, early detection of the post recovery complication might prevent the severity of the complication and can be recovered. As per cases reported, post covid extrapulmonary complications were more than pulmonary complications. However, the post covid pulmonary complications were found to be more lethal and nonrecoverable in most of the cases than extrapulmonary complications. Methods The present review is an attempt to reveal the role and importance of biomarkers associated with critical post covid pulmonary complications. COVID-19 is associated with post-covid pulmonary fibrosis, pulmonary endothelial dysfunction, pulmonary aspergillosis, pulmonary mucormycosis, biomarkers and WHO, as keywords were used to retrieve updated information. PubMed, and Google Scholar were used as search engines for this. Results There must be a better knowledge of the post-COVID-19 pulmonary problems in terms of systemic pathophysiological results to create multidisciplinary clinics to address both long-term symptoms and potential long-term consequences. This can be achieved by revealing the molecular pathogenesis that can be validated by certain biomarkers and various diagnostic techniques. Accordingly, the clinical program can be designed to treat and effectively manage the post covid pulmonary complications in early-stage to prevent mortality. Conclusion In order to deal with the specific logistical problems given by pandemic circumstances, effective interdisciplinary collaboration models draw on experiences learned during the early phases of the pandemic.
引用
收藏
页码:712 / 725
页数:14
相关论文
共 50 条
  • [21] Inflammatory biomarkers as predictors of intubation and mortality in severe COVID-19
    Garcia Estudillo, Diego Alexis
    Emmanuel Vega-Sanchez, Angel
    Rojas-Serrano, Jorge
    Edith Mejia-Avila, Mayra
    Norberto Mateos-Toledo, Heidegger
    Estrada-Garrido, Andrea
    Saul Castillo-Pedroza, Jonathan
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [22] The association between different predictive biomarkers and mortality of COVID-19
    Narges Ansari
    Mina Jahangiri
    Kimia Shirbandi
    Mina Ebrahimi
    Fakher Rahim
    Bulletin of the National Research Centre, 46 (1)
  • [23] Biomarkers Associated with Cardiovascular Morbidity and Mortality in COVID-19 Patients
    Houle, M.
    Dharia, I.
    Roman, A.
    Darwish, C.
    Smith, S.
    Zhang, S.
    Krepp, J.
    Gomberg-Maitland, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [24] Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19
    Qin, Juan-Juan
    Cheng, Xu
    Zhou, Feng
    Lei, Fang
    Akolkar, Gauri
    Cai, Jingjing
    Zhang, Xiao-Jing
    Blet, Alice
    Xie, Jing
    Zhang, Peng
    Liu, Ye-Mao
    Huang, Zizhen
    Zhao, Ling-Ping
    Lin, Lijin
    Xia, Meng
    Chen, Ming-Ming
    Song, Xiaohui
    Bai, Liangjie
    Chen, Ze
    Zhang, Xingyuan
    Xiang, Da
    Chen, Jing
    Xu, Qingbo
    Ma, Xinliang
    Touyz, Rhian M.
    Gao, Chen
    Wang, Haitao
    Liu, Liming
    Mao, Weiming
    Luo, Pengcheng
    Yan, Youqin
    Ye, Ping
    Chen, Manhua
    Chen, Guohua
    Zhu, Lihua
    She, Zhi-Gang
    Huang, Xiaodong
    Yuan, Yufeng
    Zhang, Bing-Hong
    Wang, Yibin
    Liu, Peter P.
    Li, Hongliang
    HYPERTENSION, 2020, 76 (04) : 1104 - 1112
  • [25] Urine biomarkers for the prediction of mortality in COVID-19 hospitalized patients
    Daniel Morell-Garcia
    David Ramos-Chavarino
    Josep M. Bauça
    Paula Argente del Castillo
    Maria Antonieta Ballesteros-Vizoso
    Luis García de Guadiana-Romualdo
    Cristina Gómez-Cobo
    J. Albert Pou
    Rocío Amezaga-Menéndez
    Alberto Alonso-Fernández
    Isabel Llompart
    Ana García-Raja
    Scientific Reports, 11
  • [26] Hematologic Evaluation of Children with COVID-19 Infection: Mortality Biomarkers
    Aminasnafi, Ali
    Heidari, Solmaz
    Alisamir, Mohsen
    Mirkarimi, Mohammadreza
    Namehgoshayfard, Najmeh
    Pezeshki, Seyed M. S.
    CLINICAL LABORATORY, 2022, 68 (04) : 784 - 790
  • [27] Predictive biomarkers of mortality in critically ill patients with COVID-19
    Sirvent, J. M.
    Baro, A.
    Morales, M.
    Sebastian, P.
    Saiz, X.
    MEDICINA INTENSIVA, 2022, 46 (02) : 94 - 96
  • [28] THE MOST INFORMATIVE BIOMARKERS AS PREDICTORS OF MORTALITY IN COVID-19 PNEUMONIA
    Huba, Y.
    Bielosludtseva, K.
    Konopkina, L.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [29] Urine biomarkers for the prediction of mortality in COVID-19 hospitalized patients
    Morell-Garcia, Daniel
    Ramos-Chavarino, David
    Bauca, Josep M.
    Argente del Castillo, Paula
    Antonieta Ballesteros-Vizoso, Maria
    Garcia de Guadiana-Romualdo, Luis
    Gomez-Cobo, Cristina
    Albert Pou, J.
    Amezaga-Menendez, Rocio
    Alonso-Fernandez, Alberto
    Llompart, Isabel
    Garcia-Raja, Ana
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [30] Nirmatrelvir-Ritonavir and COVID-19 Mortality and Hospitalization Among Patients With Vulnerability to COVID-19 Complications
    Dormuth, Colin R.
    Kim, Jason D.
    Fisher, Anat
    Piszczek, Jolanta
    Kuo, I. Fan
    JAMA NETWORK OPEN, 2023, 6 (10) : E2336678